• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压专科医生和非专科医生在真实环境中治疗高血压患者的目标血压达标率。

Achievement rate of target blood pressure in patients with hypertension treated by hypertension specialists and non-specialists in a real-world setting.

机构信息

Health Administration Center, University of the Ryukyus, Okinawa, Japan.

Department of Cardiovascular Medicine, Nephrology and Neurology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.

出版信息

Hypertens Res. 2023 Nov;46(11):2460-2469. doi: 10.1038/s41440-023-01362-3. Epub 2023 Jul 6.

DOI:10.1038/s41440-023-01362-3
PMID:37414873
Abstract

Hypertension remains a major global healthcare issue. Considering that most Japanese patients with hypertension are managed by general practitioners, hypertension specialists should be involved in actual clinical practice. We investigated the blood pressure (BP), guidelines recommended for achievement rate of the target BP, and clinical variables of patients with hypertension treated by hypertension specialists and those treated by non-specialists in a real-world setting. Factors associated with the target BP achievement in this population were also investigated. Outpatients with hypertension from 12 medical facilities in Okinawa Prefecture were enrolled (n = 1469 [specialist group, 794; non-specialist group, 675]; mean age, 64.2 years; females, 45.8%). For all patients, BP and rate of the target BP achievement were 129.0 ± 15.5/74.6 ± 10.6 mmHg, and 51.8%, respectively. BP and the rate of target of BP achievement were 128.0 ± 15.1/73.4 ± 10.4 mmHg and 56.7% in the specialist group, and they were 130.1 ± 15.9/76.0 ± 10.8 mmHg and 46.1% in the non-specialist group. The urinary salt excretion and obesity rates were comparable between the specialist and non-specialist groups. Multivariable logistic analyses indicated that hypertension specialists and good medication adherence were positive factors, whereas obesity, chronic kidney disease, diabetes mellitus, and urinary salt excretion were inverse factors associated with target BP achievement in this population. Initiatives for salt reduction, medication adherence, and proper obesity management are crucial to improving BP management in patients with hypertension. Hypertension specialists are expected to play an essential role in them. For all patients, the target blood pressure (BP) achievement rate were 51.8%. Hypertension specialists and good medication adherence were positive factors in achieving target BP; conversely, obesity, diabetes mellitus, chronic kidney disease, and high urinary salt excretion were inverse factors in achieving target BP among patients with hypertension.

摘要

高血压仍然是一个主要的全球医疗保健问题。考虑到大多数日本高血压患者由全科医生管理,高血压专家应参与实际的临床实践。我们在真实环境中调查了高血压专家和非专家治疗的高血压患者的血压(BP)、目标 BP 达标率的指南推荐值和临床变量。还调查了该人群中与目标 BP 达标相关的因素。从冲绳县的 12 家医疗机构招募了高血压门诊患者(n=1469[专家组,794;非专家组,675];平均年龄 64.2 岁;女性 45.8%)。对于所有患者,BP 和目标 BP 达标率分别为 129.0±15.5/74.6±10.6mmHg 和 51.8%。在专家组中,BP 和目标 BP 达标率分别为 128.0±15.1/73.4±10.4mmHg 和 56.7%,而非专家组中分别为 130.1±15.9/76.0±10.8mmHg 和 46.1%。专家组和非专家组的尿盐排泄率和肥胖率相当。多变量逻辑分析表明,高血压专家和良好的药物依从性是积极因素,而肥胖、慢性肾脏病、糖尿病和尿盐排泄是该人群中与目标 BP 达标相关的负性因素。减少盐摄入、提高药物依从性和适当控制肥胖是改善高血压患者血压管理的关键。高血压专家有望在其中发挥重要作用。对于所有患者,目标血压(BP)达标率为 51.8%。高血压专家和良好的药物依从性是达到目标 BP 的积极因素;相反,肥胖、糖尿病、慢性肾脏病和高尿盐排泄是高血压患者达到目标 BP 的负性因素。

相似文献

1
Achievement rate of target blood pressure in patients with hypertension treated by hypertension specialists and non-specialists in a real-world setting.高血压专科医生和非专科医生在真实环境中治疗高血压患者的目标血压达标率。
Hypertens Res. 2023 Nov;46(11):2460-2469. doi: 10.1038/s41440-023-01362-3. Epub 2023 Jul 6.
2
Altered dietary salt intake for preventing diabetic kidney disease and its progression.改变膳食盐摄入量以预防糖尿病肾病及其进展。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Higher blood pressure targets for hypertension in older adults.老年人高血压的更高血压目标
Cochrane Database Syst Rev. 2024 Dec 17;12(12):CD011575. doi: 10.1002/14651858.CD011575.pub3.
5
Effect of longer-term modest salt reduction on blood pressure.长期适度减少盐分摄入对血压的影响。
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD004937. doi: 10.1002/14651858.CD004937.pub2.
6
Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.用低钠盐替代物(LSSS)代替盐以促进成年人、儿童和孕妇的心血管健康。
Cochrane Database Syst Rev. 2022 Aug 10;8(8):CD015207. doi: 10.1002/14651858.CD015207.
7
Blood pressure targets for hypertension in people with diabetes mellitus.糖尿病患者高血压的血压目标
Cochrane Database Syst Rev. 2013 Oct 30;2013(10):CD008277. doi: 10.1002/14651858.CD008277.pub2.
8
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.低盐饮食与高盐饮食对血压、肾素、醛固酮、儿茶酚胺、胆固醇和甘油三酯的影响。
Cochrane Database Syst Rev. 2020 Dec 12;12(12):CD004022. doi: 10.1002/14651858.CD004022.pub5.
9
Cochrane in context: pharmacological interventions for hypertension in children.Cochrane背景下:儿童高血压的药物干预
Evid Based Child Health. 2014 Sep;9(3):581-3. doi: 10.1002/ebch.1975.
10
Pharmacological interventions for hypertension in children.儿童高血压的药物干预措施。
Evid Based Child Health. 2014 Sep;9(3):498-580. doi: 10.1002/ebch.1974.

引用本文的文献

1
Home blood pressure-based treatment with hypertension specialists: a better strategy for overcoming uncontrolled blood pressure.由高血压专科医生进行基于家庭血压的治疗:克服血压控制不佳的更好策略。
Hypertens Res. 2025 Apr;48(4):1656-1659. doi: 10.1038/s41440-025-02140-z. Epub 2025 Feb 13.
2
A decision rule algorithm for the detection of patients with hypertension using claims data.一种利用理赔数据检测高血压患者的决策规则算法。
J Diabetes Metab Disord. 2024 Dec 20;24(1):21. doi: 10.1007/s40200-024-01519-y. eCollection 2025 Jun.
3
Home blood pressure control and prescribing patterns of anti-hypertensive medications in a home blood pressure-based hypertension-specialized clinic in Japan: a sub-analysis of the Ohasama study.

本文引用的文献

1
Dietary salt intake in Japan - past, present, and future.日本的膳食盐摄入量——过去、现在与未来
Hypertens Res. 2022 May;45(5):748-757. doi: 10.1038/s41440-022-00888-2. Epub 2022 Mar 16.
2
Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases.亚洲高血压学会网络声明:《冲绳宣言》——关于亚洲国家和地区高血压学会团结起来战胜高血压及高血压相关疾病
Hypertens Res. 2022 Jan;45(1):1-2. doi: 10.1038/s41440-021-00781-4. Epub 2021 Nov 9.
3
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association.
日本一家基于家庭血压的高血压专科诊所的家庭血压控制及抗高血压药物处方模式:大崎研究的子分析
Hypertens Res. 2025 Jan;48(1):26-36. doi: 10.1038/s41440-024-01954-7. Epub 2024 Oct 28.
4
Overcoming Clinical Inertia in the Treatment of Hypertension.克服高血压治疗中的临床惰性
Intern Med. 2025 Feb 1;64(3):359-366. doi: 10.2169/internalmedicine.3747-24. Epub 2024 Jun 13.
药物依从性与血压控制:美国心脏协会的科学声明。
Hypertension. 2022 Jan;79(1):e1-e14. doi: 10.1161/HYP.0000000000000203. Epub 2021 Oct 7.
4
Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.数字治疗系统在原发性高血压管理中的疗效:HERB-DH1 关键试验。
Eur Heart J. 2021 Oct 21;42(40):4111-4122. doi: 10.1093/eurheartj/ehab559.
5
Salt and potassium intake evaluated with spot urine and brief questionnaires in combination with blood pressure control status in hypertensive outpatients in a real-world setting.在现实环境中,通过即时尿样和简短问卷评估盐和钾的摄入量,并结合高血压门诊患者的血压控制状况。
Hypertens Res. 2021 Oct;44(10):1316-1325. doi: 10.1038/s41440-021-00707-0. Epub 2021 Aug 3.
6
Long-term effects of weight-reducing drugs in people with hypertension.减肥药物对高血压患者的长期影响。
Cochrane Database Syst Rev. 2021 Jan 17;1(1):CD007654. doi: 10.1002/14651858.CD007654.pub5.
7
Validity Assessment of Self-reported Medication Use for Hypertension, Diabetes, and Dyslipidemia in a Pharmacoepidemiologic Study by Comparison With Health Insurance Claims.在一项药物流行病学研究中,通过与健康保险索赔记录比较评估高血压、糖尿病和血脂异常患者自报用药的有效性。
J Epidemiol. 2021 Sep 5;31(9):495-502. doi: 10.2188/jea.JE20200089. Epub 2020 Dec 22.
8
Validation of self-reported medication use for hypertension, diabetes, and dyslipidemia among employees of large-sized companies in Japan.验证日本大型公司员工高血压、糖尿病和血脂异常患者的自我报告用药情况。
J Occup Health. 2020 Jan;62(1):e12138. doi: 10.1002/1348-9585.12138.
9
JSH Statement: Tokyo declaration promoting salt reduction by the Japanese Society of Hypertension-the JSH Tokyo declaration.日本高血压学会声明:东京宣言——日本高血压学会促进减盐的东京宣言
Hypertens Res. 2020 Nov;43(11):1133-1134. doi: 10.1038/s41440-020-0479-0. Epub 2020 Jun 1.
10
Physician and patient perspectives on hypertension management and factors associated with lifestyle modifications in Japan: results from an online survey.医生和患者对高血压管理的看法以及与日本生活方式改变相关的因素:一项在线调查的结果。
Hypertens Res. 2020 May;43(5):450-462. doi: 10.1038/s41440-020-0398-0. Epub 2020 Jan 29.